Evaluation of liver elastography as a monitoring tool of biliary dilatation therapy in primary sclerosing cholangitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00036006

Enrollment

Registered

2025-02-19

Start date

2025-03-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K83.00 primarily sclerosing cholangitis

Interventions

Group 1: PSC adults suffered from PSC who receive a shear wave blast and a fibroscan before and after therapy as part of their stay in the clinic in addition to their biliary dilation therapy. The fir

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients suffering from PSC, patients who receive dilation therapy anyway as part of an ERCP

Exclusion criteria

Exclusion criteria: Pregnancy, LTX, other differential diagnostic diseases

Design outcomes

Primary

Measure	Time frame
Parameters of the Fibroscan and shear wave blastography	—

Secondary

Measure	Time frame
Laboratory parameters, sonographic representation of the biliary tract	—

Countries

Germany

Contacts

Public ContactJulia Kälsch

Universitätsklinkum Essen, Klinik für Gastroenterologie, Hepatologie und Tranplantationsmedizin

julia.kaelsch@uk-essen.de+49 (0)201 – 723 – 361

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026